Simplex Trading’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
Other funds holding SLNO
ACA
VCM
NCM
PCH
KCM
Simplex Trading's SLNO Position: Q1 2026 in Review
Simplex Trading reduced its Soleno Therapeutics (SLNO) stake by 63% in Q1 2026, selling an estimated $1.21M and leaving 18,166 shares worth $608K. The position accounts for ﹤0.01% of the portfolio, ranked #3044.
Simplex Trading first reported a position in SLNO in Q4 2020 and has held it in 10 quarters since. The position peaked at $2.27M in Q4 2025. 225 funds tracked by Wall St. Rank hold SLNO as of Q1 2026.
- Simplex Trading held 18,166 shares of Soleno Therapeutics worth $608K as of Q1 2026.
- Simplex Trading sold 30,942 Soleno Therapeutics shares in Q1 2026, an estimated $1.21M.
- Soleno Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #3044 holding.
- Simplex Trading first reported a position in Soleno Therapeutics in Q4 2020 and has held it in 10 quarters since.
- Simplex Trading's Soleno Therapeutics position peaked at $2.27M in Q4 2025.
- 225 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.